AI’s Role in Global Health Policy Explored in New Research

By Sumona Bose

January 9, 2024

Introduction

Artificial intelligence (AI) has the potential to transform global health policy, according to a recent study published in the Journal of Health Policy and Planning. The research highlights the various ways in which AI can contribute to inclusive healthcare practices and ethical access, while also identifying areas for improvement. The study emphasizes that AI has primarily been used in delivering public services rather than policymaking. However, the researchers argue that AI can play a crucial role in shaping global health policy by providing valuable insights and analysis. By harnessing the power of big data and AI, policymakers can assess the potential outcomes of their interventions and make more informed decisions.

AI’s Potential in Global Health

One of the key benefits of AI in health policy is its ability to analyze heterogeneous data from various sources, including healthcare devices, clinical records, and environmental data. This comprehensive analysis can help policymakers understand the complex factors that influence public health, such as access to healthcare, socioeconomic conditions, and information systems.The researchers also highlight the importance of considering multiple dimensions when developing policy options. They suggest that future studies should provide policymakers with real-time learning opportunities, address pandemics, and prevent non-communicable diseases. By tracking key performance indicators like mortality, morbidity, and life expectancy, policymakers can make evidence-based decisions that improve overall health outcomes.

Figure 1: A Framework for Interactions between AI and the elements of health policy triangle.

AI’s Contribution to Global Health Policy

Furthermore, the study emphasizes the need for transparency and accountability in policymaking. AI can help policymakers consider factors like public preferences, societal voices, and institutional transparency when developing policies. This ensures that policies are aligned with the needs and values of the population, ultimately improving life expectancy, quality of life, and social well-being.The researchers also highlight specific areas where AI can enhance global health policy. For example, AI can improve situational awareness by identifying the causes of policy failure and providing early crisis warnings. It can also reduce decision-making bias by exploring the social context and improving communication effectiveness. Additionally, AI applications like geographic information systems (GIS) can integrate and analyze geospatial data, enabling better disease surveillance and prevention.

Figure 2: A Framework for AI-equipped policymaking: existing knowledge and future directions

Conclusion

The study concludes by emphasizing that AI has the potential to reconfigure the policy process by enabling new methods of data collection, analysis, and decision-making. By equipping health systems with AI capabilities, policymakers can make more informed decisions and achieve progressive goals.Overall, this research highlights the significant role that AI can play in shaping global health policy. By leveraging AI’s capabilities, policymakers can improve healthcare access, address inequalities, and make evidence-based decisions that benefit global healthcare.

Reference url

Recent Posts

Strategic Avalere Health Appointments Enhance Leadership in Navigating US Healthcare Policy Changes

By João L. Carapinha

December 17, 2025

Avalere Health strengthened its appointments, with Matt Kazan returning as Senior Vice President of Policy, where he previously served as a former top advisor on the US Senate Committee on Finance, and he will now lead the policy team amid changes like the Inflation Reduction Act. Laura Housman, ...
CHMP Meeting Highlights: December 2025 Advances in New Medicines Approvals

By HEOR Staff Writer

December 16, 2025

The CHMP meeting highlights from December 2025 reveal major advancements in drug approvals. What were the key outcomes of the EMA's Committee for Medicinal Products for Human Use session held December 8-11? The committee recommended seven new medicines for approval. These target critical areas li...
AKEEGA BRCA2 Approval: Landmark FDA Decision for Precision Therapy in Aggressive Prostate Cancer
AKEEGA BRCA2 Approval Ushers in Precision Era for mCSPC The AKEEGA BRCA2 approval by the U.S. Food and Drug Administration (FDA) on December 12, 2025, represents a breakthrough for patients with BRCA2-mutated metastatic castration-sensitive prostate cancer (mCSPC). Johnson & Johnson...